IL5 and eosinophilic esophagitis: Some randomized clinical trials have also evaluated the efficacy of IL-5 inhibitors in patients with EoE [39,40,41], and it was shown that, despite a significant reduction in eosinophil infiltration, its effectiveness on symptoms was limited.